Keyphrases
Autoimmunity
100%
New Targets
100%
Intravenous Immunoglobulin (IVIg)
100%
B Cell Activating Factor
100%
TNF Superfamily
100%
Proliferation-inducing Ligand
40%
Recombinant
20%
Autoimmune Disease
20%
Apoptosis
10%
Deleterious Effects
10%
B Lymphocytes
10%
Therapeutic Effect
10%
Overproduction
10%
Enzyme-linked Immunosorbent Assay (ELISA)
10%
B Cells
10%
Pathological Conditions
10%
Western Blot Analysis
10%
Labeling Method
10%
Lymphoid Malignancies
10%
Cell-mediated
10%
Steric Hindrance
10%
Anti-apoptosis
10%
F(ab')2 Fragment
10%
Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling
10%
Annexin V Binding
10%
Non-glycosylated
10%
Immunoglobulin Preparations
10%
β-Cell Survival
10%
Binding Method
10%
Ligand Specificity
10%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
Tumor Necrosis Factor
100%
Autoimmunity
100%
B Cell Activating Factor
100%
APRIL Protein
36%
B Cell
27%
Autoimmune Disease
18%
Western Blot
9%
Cell Survival
9%
Enzyme-Linked Immunosorbent Assay
9%
Stereospecificity
9%
Programmed Cell Death
9%
Biochemistry, Genetics and Molecular Biology
Intravenous Immunoglobulin
100%
Tumor Necrosis Factor
100%
Autoimmunity
100%
B-Cell Activating Factor
100%
B Cell
27%
Western Blot
9%
Enzyme
9%
Cell Survival
9%
Labeling Technique
9%
Stereospecificity
9%
Terminal Deoxynucleotidyl Transferase
9%
TUNEL Assay
9%
Programmed Cell Death
9%
Lipocortin
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Tumor Necrosis Factor
100%
Immunoglobulin
100%
B Cell Activating Factor
100%
APRIL Protein
36%
Autoimmune Disease
18%
Western Blot
9%
Antiapoptotic
9%
Enzyme-Linked Immunosorbent Assay
9%
Therapeutic Effect
9%
Lipocortin 5
9%
DNA Nucleotidylexotransferase
9%